
20 Mar '26
24 Mar '26
₹117 - ₹124
₹2,48,000
1,000
BSE
23,50,000
Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals — including high-cost oral and injectable medications used to treat complex chronic conditions — across both domestic and international markets. The company’s portfolio includes a wide range of speciality pharmaceutical finished
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 0% | -- |
| Non-Institutional Investors (NIIs) | 50% | 11,75,000 crores |
| Retail Individual Investors (RIIs) | 50% | 11,75,000 crores |
Diversified Global Presence
Diversified Product Portfolio
Long Standing Client Relationship
Experienced Promoters and Management Team
Quality Assurance
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 25 Mar '26 | 30 Mar '26 | 27 Mar '26 |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 23,50,000 shares (aggregating up to ₹2,48,000 crores) |
| Fresh Issue | 2,20,000 shares (aggregating up to ₹22,00,000 crores) |
| Offer for Sale | 0 shares of ₹10 (aggregating up to To be announced) |
| Issue Type | Bookbuilding IPO |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 6435796 shares |
| Post-Issue Shareholding | 8785796 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Speciality Medicines ipo has been designed to ensure broad participation while maintaining optimal price discovery.
913 One World West S No 396 FP 119 Village Vejalpur Ahmadabad City Ahmedabad
Skyline Financial Services Pvt Ltd
| Book Running Lead Manager(s) |
|---|
| Unistone Capital Pvt Ltd |